Lavipharm S.A. (ATH:LAVI)

Lavipharm Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.62	6.11	5.59	8.44	18.24	1.64
Short-Term Investments	-	-	-	-	-	0
Trading Asset Securities	-	-	-	0	0	-
Cash & Short-Term Investments	3.62	6.11	5.59	8.44	18.24	1.64
Cash Growth	-41.39%	9.25%	-33.76%	-53.75%	1013.12%	-15.99%
Accounts Receivable	18.77	19.03	12.42	12.17	8.68	7.58
Other Receivables	2.69	3.6	3.72	2.85	5.2	5.33
Receivables	21.46	22.63	16.14	16.57	15.43	14.45
Inventory	26.03	22.94	20.49	16.21	10.44	9.24
Prepaid Expenses	-	1.22	0.86	1.38	-	-
Other Current Assets	2	0.3	1.92	3.06	1.49	0.64
Total Current Assets	53.1	53.2	45	45.65	45.6	25.96
Property, Plant & Equipment	21.73	21.97	21.36	19.54	17.06	17.46
Long-Term Investments	0.2	0.2	0	1.05	0.52	-
Other Intangible Assets	51.15	41.84	45.18	41.04	44.02	1.31
Long-Term Deferred Tax Assets	4.45	4.94	6.55	1.25	2.37	3.06
Long-Term Deferred Charges	7.89	7.09	4.5	3.5	2.18	1.83
Other Long-Term Assets	1	1	2.9	2.75	2.42	3.12
Total Assets	139.52	130.22	125.48	114.79	114.17	52.74

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	7.78	9.68	8.18	8.03	6.3	4.16
Accrued Expenses	2.21	4	2.81	3.06	6.65	4.46
Short-Term Debt	9.05	9.1	9.24	6.59	21.71	21.4
Current Portion of Long-Term Debt	2.18	1.43	1.43	1.51	-	-
Current Portion of Leases	1.42	1.42	0.91	0.68	0.52	0.66
Current Income Taxes Payable	1.21	0.54	0.25	0.24	0.51	0.1
Current Unearned Revenue	0.28	0.38	0.47	0.51	0.42	0.42
Other Current Liabilities	19.27	17.43	15.85	15.17	9.63	9.87
Total Current Liabilities	43.39	43.98	39.13	35.8	45.74	41.07
Long-Term Debt	18.63	10.22	12.17	12.7	3.96	4
Long-Term Leases	10.01	10.61	10.17	11	10.99	11.28
Pension & Post-Retirement Benefits	1.17	1.08	0.95	1.08	0.94	1.09
Other Long-Term Liabilities	9.97	7.92	10.1	11.44	12.23	5.25
Total Liabilities	83.16	73.81	72.52	72.02	73.86	62.68

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	51.23	50.71	50.61	50.36	50.36	51.08
Additional Paid-In Capital	7.13	7.06	7.17	7.41	7.41	84.42
Retained Earnings	-18.18	-18.74	-21.35	-30.24	-32.11	-159.96
Comprehensive Income & Other	16.18	17.38	16.56	15.21	14.62	14.48
Total Common Equity	56.36	56.42	52.98	42.74	40.28	-9.98
Minority Interest	-0.01	-0.01	-0.01	0.03	0.04	0.04
Shareholders' Equity	56.36	56.41	52.97	42.77	40.31	-9.94
Total Liabilities & Equity	139.52	130.22	125.48	114.79	114.17	52.74

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	41.28	32.78	33.92	32.48	37.18	37.33
Net Cash (Debt)	-37.66	-26.67	-28.34	-24.04	-18.93	-35.69
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.22	-0.16	-0.17	-0.14	-0.88	-2.10
Filing Date Shares Outstanding	170.78	169.04	168.69	167.87	167.87	17.03
Total Common Shares Outstanding	170.78	169.04	168.69	167.87	167.87	17.03
Working Capital	9.71	9.22	5.88	9.85	-0.14	-15.11
Book Value Per Share	0.33	0.33	0.31	0.25	0.24	-0.59
Tangible Book Value	5.21	14.59	7.79	1.69	-3.74	-11.29
Tangible Book Value Per Share	0.03	0.09	0.05	0.01	-0.02	-0.66
Land	1.93	1.93	1.93	1.93	1.93	1.93
Buildings	3.27	3.2	2.72	1.74	1.53	1.49
Machinery	22.81	22.5	21.45	21.14	19.31	19.09

Data Source: S&P Global Market Intelligence Last updated: Sep 17, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 13, 2026

Data Sources Report a data error